International collaboration to assess the risk of Guillain Barre Syndrome

In Partnering and Corporate strategy, Regulation and Policy by Freya SmaleLeave a Comment

Caitlin Dodd

International collaboration could be the answer to effective global vaccine distribution- Tell us your views below!

The internet has facilitated a globalization of safety concerns as a consequence of a globalization of vaccine marketing. Caitlin Dodd, Biostatistician/Epidemiologist, Center for Global Health, University of Cincinnati Children’s Hospital joined us at the World Vaccine Congress 2012 in Washington to discuss this globalization. Increasingly, there is a trend for new vaccines to be introduced early or even first in developing countries. Over the next decade, Caitlin Dodd predicts that many more vaccines will be introduced into LMIC. International collaboration is needed for effective global vaccine distribution. A good example of effective international collaboration is the success of the introduction of the Meningitis vaccine in Burkina Faso.

Why not download the full presentation and discover more about International collaboration to assess the risk of Guillain Barre Syndrome following Pandemic Influenza vaccine:

· Assessing the self-controlled case series methodology and its applicability to the study question through simulation

· Compiling and analyzing vaccine safety data from 15 sites world-wide in a proof of concept study

· Expanding this international collaborative framework to encourage participation of developing countries

· Future Directions: PREVENT (PRogram Enhancing Vaccine Epidemiology Networks and Training)

Download the full presentation here!

For more updates on the vaccines industry, follow us on Twitter:  @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Comment

Current ye@r *